[The Role of Percutaneous Coronary Revascularization in Chronic Coronary Syndromes]

Philipp Jakob1, Erik W Holy1, Patrick Siegrist1

  • 1Klinik für Kardiologie, Universitäres Herzzentrum, Universitätsspital Zürich, Zürich.

Praxis
|April 28, 2021
PubMed

Insights

Percutaneous coronary revascularization is a key treatment for chronic coronary syndromes, alongside lifestyle changes and optimal medical therapy. This review focuses on the 2019 European Society of Cardiology guidelines for managing these heart conditions.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Coronary heart disease (CHD) is a major global health burden, causing significant morbidity and mortality.
  • Effective management of CHD requires a multifaceted approach, including lifestyle modifications, pharmacotherapy, and revascularization procedures.
  • Chronic coronary syndromes (CCS) represent a prevalent manifestation of CHD requiring careful diagnostic and therapeutic strategies.

Purpose of the Study:

  • To review current diagnostic and therapeutic strategies for patients with chronic coronary syndromes (CCS).
  • To highlight the recommendations from the 2019 European Society of Cardiology (ESC) guidelines for CCS management.
  • To specifically discuss the role and indications of invasive assessment and percutaneous coronary revascularization in CCS.

Main Methods:

  • Literature review focusing on diagnostic modalities for CCS.
  • Analysis of therapeutic options for CCS, including medical management and revascularization.
  • Synthesis of evidence and guidelines, particularly the 2019 ESC guidelines for CCS.

Main Results:

  • Optimal management of CCS involves a combination of lifestyle changes, optimal medical therapy, and consideration of revascularization.
  • Invasive assessment plays a crucial role in guiding treatment decisions for selected CCS patients.
  • Percutaneous coronary revascularization is an important therapeutic option for specific patient subgroups within CCS.

Conclusions:

  • The management of CCS requires a comprehensive strategy tailored to individual patient needs.
  • Adherence to updated guidelines, such as the 2019 ESC recommendations, is essential for optimal patient outcomes.
  • Percutaneous coronary revascularization, when appropriately indicated, can significantly improve symptoms and prognosis in patients with chronic coronary syndromes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
93
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
73
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
95
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
108
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
67
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
101